ELIZABETH SANDY: Open Payments
NPI 1285260745 · WEST HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 13 payments from 6 companies in 2025. Trend: 2023 $88 · 2024 $1,092 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $59 |
| Ardelyx, Inc. | 2 | $40 |
| Novocure Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: VRAYLAR, JARDIANCE, Kerendia, IBSRELA, Optune Gio, CAPLYTA.
Industry payments across CA — which companies pay providers there.
